Correlation Between Sinphar Pharmaceutical and CHC Healthcare

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and CHC Healthcare Group, you can compare the effects of market volatilities on Sinphar Pharmaceutical and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and CHC Healthcare.

Diversification Opportunities for Sinphar Pharmaceutical and CHC Healthcare

0.52

Correlation Coefficient

Sinphar Pharmaceutical  CHC Healthcare

Very weak diversification

The 3 months correlation between Sinphar and CHC is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and CHC Healthcare go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and CHC Healthcare

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the CHC Healthcare. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 1.38 times less risky than CHC Healthcare. The stock trades about -0.23 of its potential returns per unit of risk. The CHC Healthcare Group is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  3,980  in CHC Healthcare Group on September 22, 2024 and sell it today you would earn a total of  35.00  from holding CHC Healthcare Group or generate 0.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  CHC Healthcare Group

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

CHC Healthcare Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CHC Healthcare Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, CHC Healthcare is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Sinphar Pharmaceutical and CHC Healthcare

The main advantage of trading using opposite Sinphar Pharmaceutical and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.

The idea behind Sinphar Pharmaceutical Co and CHC Healthcare Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.